Meeting minutes of the Vaccine Benefit Risk Expert Working Group from the Covid-19 Pandemic
Meeting minutes taken from meetings of the Commission on Human Medicines' Vaccine Benefit Risk Expert Working Group (VBREWG) between 25 August 2020 and 5 May 2023.
The data on this page was temporarily withdrawn in January 2025 to uphold our commitment to providing accurate and transparent records. This process was to verify redactions, to maintain the integrity of the information, including the protection of any commercially sensitive information.
On 11 February 2025, all documents in this collection were re-published.
As part of our ongoing mission to improve transparency, we are publishing minutes taken from meetings of the Commission on Human Medicines’ Vaccine Benefit Risk Expert Working Group (VBREWG) between 25 August 2020 and 5 May 2023.
The VBREWG meetings focused on evaluating the safety, efficacy, and overall benefits versus risks of vaccines, providing expert advice and recommendations on licensing and regulatory action.
Personal data of individuals and any commercially sensitive information has been redacted, as appropriate, from these minutes.
25 August 2020 to 28 November 2020
7 December 2020 to 3 January 2021
13 January 2021 to 15 February 2021
25 February 2021 to 6 April 2021
12 April 2021 to 4 May 2021
10 May 2021 to 25 May 2021
1 June 2021 to 19 November 2021
3 December 2021 to 29 March 2022
13 April 2022 to 25 August 2022
20 September 2022 to 5 May 2023
Updates to this page
Published 9 December 2024Last updated 11 February 2025 + show all updates
-
The data on this page was temporarily withdrawn in January 2025 to uphold our commitment to providing accurate and transparent records. This process was to verify redactions, to maintain the integrity of the information, including the protection of any commercially sensitive information. On 11 February 2025, all documents in this collection were re-published.
-
Published meeting minutes of the Vaccine Benefit Risk Expert Working Group from the Covid-19 Pandemic, for meetings during the period 1 June 2021 to 5 May 2023.
-
First published.